Just – Evotec Biologics is committed to supporting partner efforts to rapidly bring safe and efficacious antibody therapeutics and recombinant vaccines to people globally
Our Call to Action:
Jim Thomas, Executive Vice President Global Head Biotherapeutics & President US Operations
We applaud the actions our partners in global health, government, academia, and in the biotechnology industry are taking to end the devastating toll of COVID-19 on lives around the world. At Just – Evotec Biologics, we stand committed and are prepared to respond rapidly with our technology, resources, and expertise to the current and future pandemics when needed. Here is a summary of our capabilities:
Our technology and resources
Our Seattle-based capabilities include: antibody discovery, molecule optimization, cell line development, media optimization for high yield production for both antibodies and protein therapeutics. We can support toxicology fills as well as flexible cGMP manufacturing. Our upstream and downstream process development capabilities are unparalleled and we also provide comprehensive analytical support, and formulation development and optimization. In combination with our preferred vendor we offer fill/finish oversight.
Our people and experience
We have a deeply experienced biologics development and manufacturing team. We formed in 2014, grew our capabilities fast, and were acquired by Evotec in 2019, thus accelerating our business and mission. During the recent COVID-19 crisis we manufactured antibodies against SARS-CoV-2 for the US Department of Defense. During the Ebola crisis, we supported regulatory agencies, global health, and biotech companies with their response efforts. Over the years, the team has brought a substantial number of molecules to the clinic, and to the market working closely with regulatory authorities. Our industry experts are available for consultation.
Our mission is to design and apply innovative technologies to create global access to biotherapeutics. We are ready and capable of joining with you, as one team, in the effort to find and quickly create global access to effective treaments that address future epidemics and pandemics.
Please let us know how we can help.